Pulmatrix Announces Stopping the PUR1900 Phase 2B Study Patient Enrollment and Closing the Study, in Agreement With Partner Cipla, to Preserve Cash and Facilitate Pursuit of Strategic Alternatives
Stock Information for Pulmatrix Inc.
Loading
Please wait while we load your information from QuoteMedia.